CRC tissues; adjoining healthy tissues; tumor tissues; adjacent normal tissues; xenograft tumor tissues
HCT116; LoVo; NCM460
cell line-derived xenograft
proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); EMT (promotes); apoptosis (inhibits); cell cycle (promotes); glycolysis (promotes); ceRNA regulation (promotes); other pathway/process (promotes)
RNase R Treatment; RT-qPCR; Microarray; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; CCK8; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Transwell Assay; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry); Bioinformatics Analysis
Circ_0000467 may provide a novel molecular target for CRC therapy.
Circ_0000467 is upregulated in CRC tissues and cell lines and functions as an oncogenic circRNA. It promotes CRC proliferation, migration, invasion, glycolysis, cell cycle progression, and tumor growth by sponging miR-330-5p to increase TYRO3 expression, while suppressing apoptosis.
0.8254
Circ_0000467 Exerts an Oncogenic Role in Colorectal Cancer via miR-330-5p-Dependent Regulation of TYRO3.
combined biological and clinical study